Advertisement
Advertisement
U.S. markets open in 4 hours 41 minutes
Advertisement
Advertisement
Advertisement
Advertisement

John Hancock Funds II Multimanager Lifestyle Moderate Portfolio Class R4 (JSLMX)

Nasdaq - Nasdaq Delayed Price. Currency in USD
Add to watchlist
12.30+0.03 (+0.24%)
At close: 08:00PM EDT
Advertisement
Full screen
Previous Close12.27
YTD Return-11.54%
Expense Ratio (net)0.00%
CategoryAllocation--30% to 50% Equity
Last Cap Gain0.00
Morningstar Rating★★★★★
Morningstar Risk RatingAverage
Sustainability RatingN/A
Net Assets3.13B
Beta (5Y Monthly)N/A
Yield2.55%
5y Average ReturnN/A
Holdings Turnover15.00%
Last Dividend0.05
Average for CategoryN/A
Inception DateOct 18, 2005
  • GlobeNewswire

    Sequana Medical to Present at BioCapital Europe and Oppenheimer’s Annual Healthcare Conference

    GHENT, Belgium, March 09, 2022 (GLOBE NEWSWIRE) -- Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today announces that Ian Crosbie, Chief Executive Officer, will present at the following upcoming investor conferences in March 2022: BioCapital Europe, Amsterdam, 10 March 2022Presentation by Ian Crosbie, CEO, on Thursday 10 March at 15:20 CET

Advertisement
Advertisement